Integrative assessment of the interaction between inflammation and hemostasis processes in patients with late-life depression: a pilot study

 

Authors

 

E.F. Vasilieva

Russian Research Center for Mental Health, Moscow, Russian Federation

A.B. Katasonov

Russian Research Center for Mental Health, Moscow, Russian Federation

O.S. Brusov

Russian Research Center for Mental Health, Moscow, Russian Federation

O.I. Patyavina

Russian Research Center for Mental Health, Moscow, Russian Federation

 

https://doi.org/10.26617/1810-3111-2026-3(132)-5-13

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2026; 3 (132):  5-13.

 

Abstract

Introduction. It has been established that proinflammatory monocytes and cytokines play a significant role in the development of systemic inflammation within the pathogenesis of mental disorders. It is known that, during inflammation, cytokines and platelets can activate monocytes and stimulate the expression of tissue factor (TF), which triggers the extrinsic coagulation pathway and induces hypercoagulability. This state drives microthrombus formation in numerous pathological processes, including those associated with neuroinflammation. Consequently, the simultaneous integrative assessment of inflammatory and hemostatic factors in patients with mental disorders is of considerable interest. Objective. To evaluate the molecular and cellular mechanisms underlying the interaction between systemic inflammation parameters and hemostatic indices in elderly patients with recurrent depressive disorder (RDD), in order to identify hypercoagulability-associated inflammation in this patient group. Materials. Prior to the initiation of psychotropic therapy, the study examined 26 female patients (aged 62–81 years) diagnosed with RDD (ICD-10 code F33) who were undergoing inpatient treatment at the Mental Health Research Center (MHRC), as well as 27 age-matched healthy women. Methods. Proinflammatory monocyte activity (PMA), levels of IL-1, IL-6, and CRP, and various hemostatic parameters ‒ including the lag period (the interval preceding clot formation) ‒ were measured. Statistical analysis was performed using parametric and non-parametric methods via the STATISTICA 13 software package and the R programming language. Results and Discussion. A comparison between female patients in the general group and healthy controls showed a statistically significant increase in PMA values and IL-6 levels, along with a shortened lag period, in a subset of patients (p<0.001, p<0.05, and p<0.05, respectively). Two clusters were identified among the patients ‒ one with low (within reference ranges) and one with high IL-6 levels ‒ which differed significantly (p<0.001) from each other. The findings acquired using the proposed integrative assessment can have clinical significance, as they allow for the detection of systemic inflammation associated with blood hypercoagulability prior to the initiation of psychopharmacotherapy; this state can be viewed as a potential marker of neuroinflammatory processes in patients with recurrent depressive disorder (RDD). Conclusion. This paper presents the results of a pilot study examining the relationship between systemic inflammation and hypercoagulability in the pathogenesis of RDD. Two clusters based on IL-6 levels were identified, suggesting biological heterogeneity among patients with RDD. These findings could be utilized in future clinical practice to mitigate neuroinflammation and improve the quality of psychopharmacotherapy. However, the observed patterns require further validation in a larger, representative patient sample.

 

Keywords: systemic inflammation, hemostasis, hypercoagulability, monocytes, platelets, IL-6, lag period, recurrent depressive disorder.

 

Article (pdf)

 

Contacts

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

For citation: Vasilieva E.F., Katasonov A.B., Brusov O.S., Patyavina O.I. Integrative assessment of the interaction between inflammation and hemostasis processes in patients with late-life depression: a pilot study. Siberian Herald of Psychiatry and Addiction Psychiatry.2026, 3 (132): 5-13. https://doi.org/10.26617/1810-3111-2026-3(132)-5-13

 

REFERENCES

  1. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007 Mar;81(3):584-92. https://doi.org/10.1189/jlb.0806510. Epub 2006 Nov 29. PMID: 17135573.
  2. Merino A, Buendia P, Martin-Malo A, Aljama P, Ramirez R, Carracedo J. Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity. J Immunol. 2011 Feb 1;186(3):1809-15.https://doi.org/10.4049/jimmunol.1001866. Epub 2010 Dec 29. PMID: 21191073.
  3. Ivanov II, Apta BHR, Bonna AM, Harper MT. Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes. Sci Rep. 2019 Sep 16;9(1):13397. https://doi.org/10.1038/s41598-019-49635-7. PMID: 31527604; PMCID: PMC6746844.
  4. Semeraro F, Ammollo CT, Semeraro N, Colucci M. Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins. Haematologica. 2009 Jun;94(6):819-26.https://doi.org/10.3324/haematol.2008.000042. Epub 2009 Apr 18. PMID: 19377079; PMCID: PMC2688573.
  5. Okajima K. SIRS and the coagulation of normality. Rinsho Byori. 2000 Jun;48(6):510-5. Japanese. PMID: 10897668.
  6. Haynes A, Linden MD, Robey E, Naylor LH, Cox KL, Lautenschlager NT, Green DJ. Relationship between monocyte-platelet aggregation and endothelial function in middle-aged and elderly adults. Physiol Rep. 2017 May;5(10):e13189.https://doi.org/10.14814/phy2.13189. PMID: 28533260; PMCID: PMC5449553.
  7. Beumer W, Drexhage RC, De Wit H, Versnel MA, Drexhage HA, Cohen D. Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrin. 2012April;37(12):1901–1911. https://doi.org/10.1016/j.psyneuen.2012.04.001.
  8. Levchuk LA, Mikhalitskaya EV, Epimakhova EV, Roschina OV, Vasilieva SN, Boiko AS, Simutkin GG, Bokhan NA, Ivanova SA. The content of immunoinflammation markers in peripheral blood mononuclears in alcohol dependence and affective disorders. Psychiatry (Moscow). 2026;24(2):60-72.https://doi.org/10.30629/2618-6667-2026-24-2-60-72(in Russian).
  9. Ferrari P, Parisi MM, Colombo R, Becker M, Fries G, Ascoli BM, Géa LP, Anna MK, Kapczinski F, Klamt F, Guma FTCR, Rosa AR, Barbé-Tuana FM. Depression and mania induce pro-inflammatory activation of macrophages following application of serum from individuals with bipolar disorder. Clin Psychopharmacol Neurosci.2018 Feb 28;16(1):103-108. https://doi.org/10.9758/cpn.2018.16.1.103. PMID: 29397672; PMCID: PMC5810451.
  10. Jackson AJ, Miller BJ. Meta-analysis of total and differential white blood cell counts in schizophrenia. Acta Psych Scand. 2020December;142(1):18-26. https://doi.org/10.1111/acps.13140.
  11. Vasilyeva EF, Sekirina TP, Sarmanova ZV, Zozulya SA, Omel'chenko MA, Klushnik TP. Estimation of level of subpopulation CD14+/CD16+ monocytes in patients with juvenile depressions. Medical Immunology (Russia). 2019;21(2):257-268. https://doi.org/10.15789/1563-0625-2019-2-257-268(inRussian).
  12. Vasilyeva EF, Oleychik IV, Baranov PA, Sizov SV, Brusov OS. Evaluation of the levels of proinflammatory activity of monocytes in depressed patients with schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11):131-136. https://doi.org/10.17116/jnevro202212211113(in Russian).
  13. Brusov OS, Oleichik IV, Karpova NS, Faktor MI, Sizov SV. Correlations between thrombodynamic parameters of coagulation and negative syndromes in patients with schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(12):86–91. https://doi.org/10.17116/jnevro202012012186(in Russian).
  14. Karpova NS, Brusov OS, Oleichik IV, Stolyarov SA, Klyushnik TP. Hemostasis system in patients with schizophrenia and schizophrenia spectrum disorders. Bull Exp Biol Med. 2024 Jan;176(3):390-393. https://doi.org/10.1007/s10517-024-06030-1. Epub 2024 Feb 12. PMID: 38345675.
  15. Vasilieva ЕF, Karpova NS, Shilov YY, Brusov OS. Cell and molecular mechanisms of proinflammatory activity of monocytes and thrombogenesis in patients with depressive syndrome. International Research Journal, 2022;12(126):1-3 https://doi.org/10.23670/IRJ.2022.126.49 (in Russian).
  16. Hoirisch-Clapauch S, Nardi AE, Gris JC, Brenner B. Coagulation and mental disorders. Rambam Maimonides Med J. 2014 Oct 29;5(4):e0036. https://doi.org/10.5041/RMMJ.10170. PMID: 25386352; PMCID: PMC4222425.
  17. Patel S, Govindarajan V, Chakravarty S, Dubey N. From blood to brain: Exploring the role of fibrinogen in the pathophysiology of depression and other neurological disorders. Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113326.https://doi.org/10.1016/j.intimp.2024.113326.
  18. Sălcudean A, Bodo CR, Popovici RA, Cozma MM, Păcurar M, Crăciun RE, Crisan AI, Enatescu VR, Marinescu I, Cimpian DM, Nan AG, Sasu AB, Anculia RC, Strete EG. Neuroinflammation-A crucial factor in the pathophysiology of depression-A comprehensive review. Biomolecules.2025 Mar 30;15(4):502.https://doi.org/10.3390/biom15040502. PMID: 40305200; PMCID: PMC12024626.
  19. Moritz AA, Terebova PS, Ivanov MV. The role of immuno-inflammatory factors in the development of negative symptoms in schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(11):42-48.https://doi.org/10.17116/jnevro202412411142 (in Russian).
  20. Šagud M, Madžarac Z, Nedic Erjavec G, Šimunović Filipčić I, Mikulić FL, Rogić D, Bradaš Z, Bajs Janović M, Pivac N. The associations of neutrophillymphocyte, platelet-lymphocyte, monocytelymphocyte ratios and immune-inflammation index with negative symptoms in patients with schizophrenia. Biomolecules. 2023 Feb 4;13(2):297. https://doi.org/10.3390/biom13020297. PMID: 36830666; PMCID: PMC9952992.
  21. Arenson EB Jr, Epstein MB, Seeger RC. Volumetric and functional heterogeneity of human monocytes. J Clin Invest. 1980 Mar;65(3):613-8. https://doi.org/10.1172/JCI109706. PMID: 7354131; PMCID: PMC371402.